Skip to main content
Erschienen in: Diabetologia 10/2012

01.10.2012 | Article

Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice

verfasst von: D. C. Henstridge, C. R. Bruce, C. P. Pang, G. I. Lancaster, T. L. Allen, E. Estevez, T. Gardner, J. M. Weir, P. J. Meikle, K. S. L. Lam, A. Xu, N. Fujii, L. J. Goodyear, M. A. Febbraio

Erschienen in: Diabetologia | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Although skeletal muscle insulin resistance has been associated with activation of c-Jun N-terminal kinase (JNK), whether increased JNK activity causes insulin resistance in this organ is not clear. In this study we examined the metabolic consequences of isolated JNK phosphorylation in muscle tissue.

Methods

Plasmids containing genes encoding a wild-type JNK1 (WT-JNK) or a JNK1/JNKK2 fusion protein (rendering JNK constitutively active; CA-Jnk) were electroporated into one tibialis anterior (TA) muscle of C57Bl/6 mice, with the contralateral TA injected with an empty vector (CON) to serve as a within-animal control.

Results

Overproduction of WT-JNK resulted in a modest (∼25%) increase in phosphorylation (Thr183/Tyr185) of JNK, but no differences were observed in Ser307 phosphorylation of insulin receptor substrate 1 (IRS-1) or total IRS-1 protein, nor in insulin-stimulated glucose clearance into the TA muscle when comparing WT-JNK with CON. By contrast, overexpression of CA-Jnk, which markedly increased the phosphorylation of CA-JNK, also increased serine phosphorylation of IRS-1, markedly decreased total IRS-1 protein, and decreased insulin-stimulated phosphorylation of the insulin receptor (Tyr1361) and phosphorylation of Akt at (Ser473 and Thr308) compared with CON. Moreover, overexpression of CA-Jnk decreased insulin-stimulated glucose clearance into the TA muscle compared with CON and these effects were observed without changes in intramuscular lipid species.

Conclusions/interpretation

Constitutive activation of JNK in skeletal muscle impairs insulin signalling at the level of IRS-1 and Akt, a process which results in the disruption of normal glucose clearance into the muscle.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520PubMedCrossRef Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520PubMedCrossRef
2.
Zurück zum Zitat Chibalin AV, Leng Y, Vieira E et al (2008) Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132:375–386PubMedCrossRef Chibalin AV, Leng Y, Vieira E et al (2008) Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132:375–386PubMedCrossRef
3.
Zurück zum Zitat Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167–179PubMedCrossRef Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167–179PubMedCrossRef
4.
Zurück zum Zitat Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336PubMedCrossRef Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336PubMedCrossRef
5.
Zurück zum Zitat Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673–1677PubMedCrossRef Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673–1677PubMedCrossRef
6.
Zurück zum Zitat Sabio G, Kennedy NJ, Cavanagh-Kyros J et al (2010) Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 30:106–115PubMedCrossRef Sabio G, Kennedy NJ, Cavanagh-Kyros J et al (2010) Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 30:106–115PubMedCrossRef
7.
Zurück zum Zitat Witczak CA, Hirshman MF, Jessen N et al (2006) JNK1 deficiency does not enhance muscle glucose metabolism in lean mice. Biochem Biophys Res Commun 350:1063–1068PubMedCrossRef Witczak CA, Hirshman MF, Jessen N et al (2006) JNK1 deficiency does not enhance muscle glucose metabolism in lean mice. Biochem Biophys Res Commun 350:1063–1068PubMedCrossRef
8.
Zurück zum Zitat Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A 103:10741–10746PubMedCrossRef Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A 103:10741–10746PubMedCrossRef
9.
Zurück zum Zitat Chung J, Nguyen AK, Henstridge DC et al (2008) HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 105:1739–1744PubMedCrossRef Chung J, Nguyen AK, Henstridge DC et al (2008) HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 105:1739–1744PubMedCrossRef
10.
Zurück zum Zitat Schenk S, Horowitz JF (2007) Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117:1690–1698PubMedCrossRef Schenk S, Horowitz JF (2007) Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117:1690–1698PubMedCrossRef
11.
12.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
13.
Zurück zum Zitat Zheng C, Xiang J, Hunter T, Lin A (1999) The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J Biol Chem 274:28966–28971PubMedCrossRef Zheng C, Xiang J, Hunter T, Lin A (1999) The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J Biol Chem 274:28966–28971PubMedCrossRef
14.
Zurück zum Zitat Fujii N, Boppart MD, Dufresne SD et al (2004) Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity. Am J Physiol Cell Physiol 287:C200–C208PubMedCrossRef Fujii N, Boppart MD, Dufresne SD et al (2004) Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity. Am J Physiol Cell Physiol 287:C200–C208PubMedCrossRef
15.
Zurück zum Zitat Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199PubMedCrossRef Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199PubMedCrossRef
16.
Zurück zum Zitat Bruce CR, Brolin C, Turner N et al (2007) Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am J Physiol Endocrinol Metab 292:E1231–E1237PubMedCrossRef Bruce CR, Brolin C, Turner N et al (2007) Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am J Physiol Endocrinol Metab 292:E1231–E1237PubMedCrossRef
17.
Zurück zum Zitat Bruce CR, Hoy AJ, Turner N et al (2009) Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58:550–558PubMedCrossRef Bruce CR, Hoy AJ, Turner N et al (2009) Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58:550–558PubMedCrossRef
18.
Zurück zum Zitat Cooney GJ, Astbury LD, Williams PF, Caterson ID (1987) Insulin response in individual tissues of control and gold thioglucose-obese mice in vivo with [1-14C]2-deoxyglucose. Diabetes 36:152–158PubMedCrossRef Cooney GJ, Astbury LD, Williams PF, Caterson ID (1987) Insulin response in individual tissues of control and gold thioglucose-obese mice in vivo with [1-14C]2-deoxyglucose. Diabetes 36:152–158PubMedCrossRef
19.
Zurück zum Zitat Hom FG, Goodner CJ, Berrie MA (1984) A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes 33:141–152PubMedCrossRef Hom FG, Goodner CJ, Berrie MA (1984) A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes 33:141–152PubMedCrossRef
20.
Zurück zum Zitat Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed
21.
Zurück zum Zitat Matthews VB, Allen TL, Risis S et al (2010) Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53:2431–2441PubMedCrossRef Matthews VB, Allen TL, Risis S et al (2010) Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53:2431–2441PubMedCrossRef
22.
Zurück zum Zitat Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275:9047–9054PubMedCrossRef Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275:9047–9054PubMedCrossRef
23.
Zurück zum Zitat Sabio G, Cavanagh-Kyros J, Barrett T et al (2010) Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes Dev 24:256–264PubMedCrossRef Sabio G, Cavanagh-Kyros J, Barrett T et al (2010) Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes Dev 24:256–264PubMedCrossRef
24.
Zurück zum Zitat Sabio G, Cavanagh-Kyros J, Ko HJ et al (2009) Prevention of steatosis by hepatic JNK1. Cell Metab 10:491–498PubMedCrossRef Sabio G, Cavanagh-Kyros J, Ko HJ et al (2009) Prevention of steatosis by hepatic JNK1. Cell Metab 10:491–498PubMedCrossRef
25.
Zurück zum Zitat Sabio G, Das M, Mora A et al (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539–1543PubMedCrossRef Sabio G, Das M, Mora A et al (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539–1543PubMedCrossRef
26.
Zurück zum Zitat Solinas G, Vilcu C, Neels JG et al (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6:386–397PubMedCrossRef Solinas G, Vilcu C, Neels JG et al (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6:386–397PubMedCrossRef
27.
Zurück zum Zitat Vallerie SN, Furuhashi M, Fucho R, Hotamisligil GS (2008) A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One 3:e3151PubMedCrossRef Vallerie SN, Furuhashi M, Fucho R, Hotamisligil GS (2008) A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One 3:e3151PubMedCrossRef
28.
Zurück zum Zitat Whitham M, Chan MH, Pal M et al (2012) Contraction-induced IL-6 gene transcription in skeletal muscle is regulated by c-jun terminal kinase/activator protein-1. J Biol Chem 287:10771–10779PubMedCrossRef Whitham M, Chan MH, Pal M et al (2012) Contraction-induced IL-6 gene transcription in skeletal muscle is regulated by c-jun terminal kinase/activator protein-1. J Biol Chem 287:10771–10779PubMedCrossRef
29.
Zurück zum Zitat Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM (2005) Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54:2351–2359PubMedCrossRef Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM (2005) Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54:2351–2359PubMedCrossRef
30.
Zurück zum Zitat Xu X, Sarikas A, Dias-Santagata DC et al (2008) The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell 30:403–414PubMedCrossRef Xu X, Sarikas A, Dias-Santagata DC et al (2008) The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell 30:403–414PubMedCrossRef
31.
Zurück zum Zitat Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C, White MF (2010) Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab 11:84–92PubMedCrossRef Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C, White MF (2010) Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab 11:84–92PubMedCrossRef
32.
Zurück zum Zitat Manning AM, Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2:554–565PubMedCrossRef Manning AM, Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2:554–565PubMedCrossRef
33.
Zurück zum Zitat Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA (2007) Lipid mediators of insulin resistance. Nutr Rev 65:S39–S46PubMedCrossRef Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA (2007) Lipid mediators of insulin resistance. Nutr Rev 65:S39–S46PubMedCrossRef
34.
Zurück zum Zitat Kumar A, Harris TE, Keller SR, Choi KM, Magnuson MA, Lawrence JC Jr (2008) Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances basal glycogen synthase activity. Mol Cell Biol 28:61–70PubMedCrossRef Kumar A, Harris TE, Keller SR, Choi KM, Magnuson MA, Lawrence JC Jr (2008) Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances basal glycogen synthase activity. Mol Cell Biol 28:61–70PubMedCrossRef
35.
Zurück zum Zitat Jaeschke A, Karasarides M, Ventura JJ et al (2006) JNK2 is a positive regulator of the cJun transcription factor. Mol Cell 23:899–911PubMedCrossRef Jaeschke A, Karasarides M, Ventura JJ et al (2006) JNK2 is a positive regulator of the cJun transcription factor. Mol Cell 23:899–911PubMedCrossRef
Metadaten
Titel
Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice
verfasst von
D. C. Henstridge
C. R. Bruce
C. P. Pang
G. I. Lancaster
T. L. Allen
E. Estevez
T. Gardner
J. M. Weir
P. J. Meikle
K. S. L. Lam
A. Xu
N. Fujii
L. J. Goodyear
M. A. Febbraio
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2652-8

Weitere Artikel der Ausgabe 10/2012

Diabetologia 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.